Post Kala-azar Dermal Leishmaniasis.
Das NK.
Indian J Dermatol. 2020 Nov-Dec;65(6):450-451. doi: 10.4103/ijd.IJD_439_20.
Post-kala-azar dermal leishmaniasis.
Pathania YS, Budania A.
QJM. 2022 Jan 5;114(11):824-825. doi: 10.1093/qjmed/hcab236.
Biomarkers in Post-kala-azar Dermal Leishmaniasis.
Zijlstra EE.
Front Cell Infect Microbiol. 2019 Jul 31;9:228. doi: 10.3389/fcimb.2019.00228. eCollection 2019.
Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination.
Kumar A, Singh VK, Tiwari R, Madhukar P, Rajneesh, Kumar S, Gautam V, Engwerda C, Sundar S, Kumar R.
Front Immunol. 2023 Aug 11;14:1236952. doi: 10.3389/fimmu.2023.1236952. eCollection 2023.
Post-Kala-Azar Dermal Leishmaniasis.
Sharma A, Bishnoi A, Parsad D.
Am J Trop Med Hyg. 2024 Jul 23;111(4):710-712. doi: 10.4269/ajtmh.24-0018. Print 2024 Oct 2.
Post kala-azar dermal leishmaniasis: A threat to elimination program.
Gedda MR, Singh B, Kumar D, Singh AK, Madhukar P, Upadhyay S, Singh OP, Sundar S.
PLoS Negl Trop Dis. 2020 Jul 2;14(7):e0008221. doi: 10.1371/journal.pntd.0008221. eCollection 2020 Jul.
Post-kala-azar dermal leishmaniasis.
Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM.
Lancet Infect Dis. 2003 Feb;3(2):87-98. doi: 10.1016/s1473-3099(03)00517-6.
Post-kala-azar dermal leishmaniasis--an overview.
Ganguly S, Das NK, Barbhuiya JN, Chatterjee M.
Int J Dermatol. 2010 Aug;49(8):921-31. doi: 10.1111/j.1365-4632.2010.04558.x.
Mechanisms of Immunopathogenesis in Cutaneous Leishmaniasis And Post Kala-azar Dermal Leishmaniasis (PKDL).
Volpedo G, Pacheco-Fernandez T, Holcomb EA, Cipriano N, Cox B, Satoskar AR.
Front Cell Infect Microbiol. 2021 Jun 8;11:685296. doi: 10.3389/fcimb.2021.685296. eCollection 2021.
The importance of T cell-derived cytokines in post-kala-azar dermal leishmaniasis.
Jafarzadeh A, Jafarzadeh S, Sharifi I, Aminizadeh N, Nozari P, Nemati M.
Cytokine. 2021 Nov;147:155321. doi: 10.1016/j.cyto.2020.155321. Epub 2020 Oct 8.
